PHOENIX NEW MED.ADR 1/48 (1PX) — Long-term Investment Intensity
PHOENIX NEW MED.ADR 1/48 (1PX) has a Long-term Investment Intensity of 6.3% as of December 2025. Long-term investments of €104.43 Million represent 6.3% of total assets of €1.65 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is PHOENIX NEW MED.ADR 1/48's book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
PHOENIX NEW MED.ADR 1/48 Long-term Investment Intensity (2021–2025)
This chart shows how PHOENIX NEW MED.ADR 1/48's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 6.3%, reflecting long-term investments of €104.43 Million against total assets of €1.65 Billion EUR. Also explore balance sheet size of PHOENIX NEW MED.ADR 1/48 for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for PHOENIX NEW MED.ADR 1/48 (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for PHOENIX NEW MED.ADR 1/48 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PHOENIX NEW MED.ADR 1/48 (1PX) market capitalisation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 6.3% | €104.43 Million | €1.65 Billion | ▲ +1.3 pp |
| 2024 | 5.0% | €85.75 Million | €1.71 Billion | ▼ -0.8 pp |
| 2023 | 5.8% | €101.53 Million | €1.76 Billion | ▲ +0.1 pp |
| 2022 | 5.6% | €114.69 Million | €2.03 Billion | ▼ -0.2 pp |
| 2021 | 5.8% | €140.53 Million | €2.41 Billion | — |